Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ascites × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 57 Prostatic Neoplasms 44 Neoplasm Metastasis 25 Multiple Myeloma 25 Osteoporosis 14 Pain 13 Carcinoma, Non-Small-Cell Lung 10 Neoplasms 9 Osteosarcoma 7 Lung Neoplasms 7 Carcinoma, Renal Cell 6 Neuroblastoma 5 Neoplasms, Plasma Cell 5 Humoral Hypercalcemia Of Malignancy 5 Fractures, Bone 4 Bone Diseases, Metabolic 4 Sarcoma, Ewing 3 Sarcoma 3 Lymphoma 3 Kidney Neoplasms 3 Bone Neoplasms 3 Bone Diseases 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Spinal Cord Compression 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Ovarian Neoplasms 2

Interventions

Quality of Life 2 Nutritional Status 2 Interviews as Topic 2 sintilimab 1 danvatirsen 1 contrast agent BR1 1 catumaxomab 1 aflibercept 1 Zoledronic Acid 1 Vascular Access Devices 1 Portasystemic Shunt, Transjugular Intrahepatic 1 Octreotide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06759064 2025-11-19

IPIZA

Qilu Hospital of Shandong University

Phase 1/2 Recruiting

Gastrointestinal

Adenocarcinoma, Ascites, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡